Last Posted: Jun-17-2019 11AM
Last Posted: Jun 16, 2019
- Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.
Snyder Susan R et al. Public health genomics 2019 Jun 1-11 - Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.
Zhang Xuchao et al. Cancer biology & medicine 2019 Feb 16(1) 189-204 - Cell-free DNA in cancer: current insights.
Fettke Heidi et al. Cellular oncology (Dordrecht) 2019 Feb 42(1) 13-28 - Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panel.
Yang Lulu et al. BMC medical genetics 2018 19(1) 212 - Where to Target? The Precision Medicine Approach to Brain Stimulation.
McMullen David P et al. Biological psychiatry 2018 84(1) e1-e2 - Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-Onset Epilepsy.
Demos Michelle et al. Frontiers in neurology 2019 10434 - Mind the gap: resources required to receive, process and interpret research-returned whole genome data.
Crawford Dana C et al. Human genetics 2019 Jun - Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses.
Henderson Raymond et al. Oncotarget 2019 May 10(36) 3408-3423 - Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?
Lee Ho-Su et al. Cells 2019 Jun 8(6) - Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai Hui et al. Journal of translational medicine 2019 Jun 17(1) 189
.png)
No hay comentarios:
Publicar un comentario